Skip to content

Clinical trials

Phase 3 Fallopian Tube Neoplasms trials in the United Kingdom

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Fallopian Tube Neoplasms Phase: Phase 3 Country / region: United Kingdom Clear all

25 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20052
20062
20071
20101
20112
20131
20141
20151
20161
20171
20181
20191
20212
20222
20231
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed14
Active, not recruiting4
Unknown status3
Recruiting2
Terminated2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Medical Research Council4
pharmaand GmbH4
AbbVie2
Amgen2
European Organisation for Research and Treatment of Cancer - EORTC2
Merck Sharp & Dohme LLC2
Advenchen Laboratories, LLC1
Corcept Therapeutics1
Eli Lilly and Company1
ImmunoGen, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Fallopian Tube Neoplasms25
Ovarian Neoplasms23
Carcinoma, Ovarian Epithelial15
Peritoneal Neoplasms5
Neoplasms3
Recurrence2
Brenner Tumor1
Endometrial Neoplasms1
Genital Neoplasms, Male1
Neoplasm Metastasis1

Trials

Showing 1 to 25 of 25. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.